Related Experiment Video

Updated: May 6, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

920

Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension

Gustavo A Heresi1, Metin Aytekin, Jeffrey P Hammel

  • 1Respiratory Institute, Cleveland Clinic, Cleveland, OH.

The European Respiratory Journal
|October 19, 2013
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

22.1K
Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
12:04

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Published on: May 9, 2018

17.2K

Related Experiment Videos

Last Updated: May 6, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

920
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

22.1K
Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
12:04

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Published on: May 9, 2018

17.2K

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

618
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
618
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

911
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
911

Articles linked to this work by shared authors, journal, and citation graph.

Predictors of long-term survival after pulmonary endarterectomy.

JTCVS open·2026

Endotypes of Vascular Health Predict Transplantation-Free Survival in Pulmonary Hypertension.

Journal of the American Heart Association·2026

Sex-based differences in long-term respiratory and pulmonary vascular outcomes after acute pulmonary embolism: A propensity-matched analysis of 795,338 patients.

Respiratory medicine·2026

Chronic Thromboembolic Pulmonary Disease Phenotypes Using Upright Invasive Cardiopulmonary Exercise Testing.

Pulmonary circulation·2026

PET Molecular Imaging and Theranostics in Lung Diseases: Making Precision Medicine a Reality.

Chest·2026

The impact of age on six-minute walk distance, functional class, and right ventricular function in pulmonary arterial hypertension.

Respiratory medicine·2026

The Role of Inflammation in the Pathogenesis of Pulmonary Fibrosis: Mechanisms and Treatment Implications.

The European respiratory journal·2026

YY1 lactylation mediates epithelial barrier dysfunction during acute lung injury.

The European respiratory journal·2026

A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with chronic obstructive pulmonary disease.

The European respiratory journal·2026

Preclinical models of COPD: a state of the art.

The European respiratory journal·2026

Pelvic venous disorders (PeVD): objective hemodynamic signature from quantitative 2-dimensional phase-contrast magnetic resonance imaging.

Journal of vascular surgery. Venous and lymphatic disorders·2026

Ultra-short-term HRV analysis in a dynamic scenario using the traditional and functional approach.

Physiological measurement·2026

Association of Intrusive Posttraumatic Stress Symptoms With Elevated C-Reactive Protein Levels in World Trade Center Responders.

The primary care companion for CNS disorders·2026

Real-Time Nanoscale Multiparametric Biophysical Phenotyping of Single Cells by Surface Plasmon Resonance Microscopy.

ACS sensors·2026

Cardiac-brain integration and stress: a mechanistic role for the heartbeat-evoked potential?

Stress (Amsterdam, Netherlands)·2026

Diagnostic Performance of Pulse Pressure Variation for Predicting Fluid Responsiveness During Spine Surgery in the Prone Position: A Systematic Review and Meta-Analysis.

Journal of neurosurgical anesthesiology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us